PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.580.04 (-0.71%)
5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.85%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-16.31%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-89.49%
Negative EBIT growth while STERV.HE is at 99.64%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-89.49%
Negative operating income growth while STERV.HE is at 99.64%. Joel Greenblatt would press for urgent turnaround measures.
-76.26%
Negative net income growth while STERV.HE stands at 87.16%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-76.43%
Negative EPS growth while STERV.HE is at 87.33%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-76.43%
Negative diluted EPS growth while STERV.HE is at 87.33%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.28%
Share change of 0.28% while STERV.HE is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.28%
Diluted share change of 0.28% while STERV.HE is zero. Bruce Berkowitz might see a minor difference that could widen over time.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
391.03%
OCF growth above 1.5x STERV.HE's 250.85%. David Dodd would confirm a clear edge in underlying cash generation.
191.44%
FCF growth above 1.5x STERV.HE's 108.97%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-3.24%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
2.12%
Positive 5Y CAGR while STERV.HE is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
3.58%
3Y revenue/share CAGR above 1.5x STERV.HE's 2.31%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
793.33%
Positive long-term OCF/share growth while STERV.HE is negative. John Neff would see a structural advantage in sustained cash generation.
43.94%
Positive OCF/share growth while STERV.HE is negative. John Neff might see a comparative advantage in operational cash viability.
4.91%
Positive 3Y OCF/share CAGR while STERV.HE is negative. John Neff might see a big short-term edge in operational efficiency.
-33.77%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-91.72%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-89.81%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
129.33%
10Y equity/share CAGR 1.25-1.5x STERV.HE's 105.66%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
48.29%
5Y equity/share CAGR at 50-75% of STERV.HE's 71.95%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
44.74%
3Y equity/share CAGR at 75-90% of STERV.HE's 52.79%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-11.53%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-13.82%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-3.77%
Negative asset growth while STERV.HE invests at 0.74%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-2.31%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-2.03%
We’re deleveraging while STERV.HE stands at 3.22%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-6.32%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.